PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in Spain
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.2111
https://www.valueinhealthjournal.com/article/S1098-3015(12)03825-9/fulltext
Section Title :
Cancer
Section Order :
764
First Page :
A421
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03825-9&doi=10.1016/j.jval.2012.08.2111